National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 3) (No. PB 46 of 2013) (Cth)

PB 46 of 2013

National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 3)

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the

Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated            26  July   2013

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health and Ageing

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 3).

(2)   This Determination may also be cited as PB 46 of 2013.

1. Commencement

This Determination commences on 1 August 2013.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Abciximab

Insert

Abiraterone

[2]     Schedule 1, after item dealing with Balsalazide

Omit

BCG Immunotherapeutic (Bacillus Calmette-Guerin/Connaught strain)

BCG-TICE (Bacillus Calmette-Guerin/Tice strain)

Insert

Bacillus Calmette and Guerin Connaught strain

Bacillus Calmette and Guerin, Tice strain

[3]     Schedule 1, after item dealing with Glycerol

Insert

Glycomacropeptide and essential amino acids

Glycomacropeptide and essential amino acids with vitamins and minerals

[4]     Schedule 1, after item dealing with Interferon gamma-1b

Insert

Ipilimumab

[5]     Schedule 1, after item dealing with Miconazole

Insert

Mifepristone

[6]     Schedule 1, after item dealing with Minoxidil

Omit

Misoprostol

[7]     Schedule 1, after item dealing with Modafinil

Omit

Montelukast

[8]     Schedule 2, after item dealing with Candesartan

Insert

Candesartan with Hydrochlorothiazide

[9]     Schedule 2, after item dealing with Lamivudine

Insert

Lamivudine with Zidovudine

[10]   Schedule 2, after item dealing with Mirtazapine

Insert

Misoprostol

[11]   Schedule 2, after item dealing with Mometasone

Insert

Montelukast

[12]   Schedule 2, after item dealing with Telmisartan

Insert

Telmisartan with Hydrochlorothiazide